Overhaul Of U.S. Preventive Services Task Force May Impact Coverage Of Screenings
Upheaval at the U.S. Preventive Services Task Force may reshape coverage of preventive care by insurance, possibly leading to removal of previously covered items.
Joshua P. Cohen, Senior Contributor
Forbes
3 min read
7/10
Key Takeaways
The USPSTF overhaul stems from a 2025 executive order imposing political vetting on federal advisory committees, breaking the panel's long-standing independence.
Over 150 million Americans could lose free access to preventive screenings if the task force downgrades 'A' or 'B' ratings for services like mammograms, colonoscopies, and lung cancer scans.
At least three USPSTF members resigned in early 2026, citing White House interference in the scientific review process.
An internal memo reveals new leadership has been instructed to weigh cost-effectiveness more heavily than population health when issuing ratings.
Democratic state attorneys general from 18 states have pre-filed legal challenges to any rule changes that strip ACA preventive care coverage.
The U.S. Preventive Services Task Force (USPSTF), the independent panel that decides which preventive screenings insurance must cover, is facing a sweeping overhaul that could strip coverage from long-protected services like mammograms and colonoscopies. The upheaval, driven by internal disputes and external political pressure, threatens to undo a cornerstone of the Affordable Care Act: free access to preventive care. The USPSTF has been the gatekeeper for millions of Americans' coverage of cancer screenings, depression assessments, and heart disease prevention. Under the ACA, insurers are required to fully cover any service that receives an 'A' or 'B' rating from the task force — no copays, no deductibles. Now, a series of proposed changes to the task force's structure, membership, and scientific review process could result in downgrading or removing many of those ratings, effectively erasing coverage requirements. The overhaul comes after years of criticism from both sides: some lawmakers argue the task force has been too slow to adopt new evidence, while others claim it has been politicized. The current administration has proposed reining in the task force's independence by stacking it with appointees who favor less government intervention in healthcare. At the center of the debate is a 2025 executive order that required all federal advisory committees to comply with strict political vetting. That order now hits the USPSTF, which had previously operated as a quasi-independent body of academic physicians and scientists. The consequences are already visible: earlier this year, the task force delayed updating its breast cancer screening guidelines, sparking fears that a future rating downgrade would eliminate free mammograms for women in their 40s. The task force's own members have resigned in protest, citing interference from the White House. The overhaul also threatens screening for colorectal cancer, lung cancer, and hepatitis C. According to an internal memo obtained by Forbes, the task force's new leadership has been told to prioritize cost-effectiveness over population health — a shift that could lead to lower ratings for expensive but life-saving tests. The implications are staggering: over 150 million Americans rely on the ACA's preventive care mandate. States are already preparing for legal battles, with Democratic attorneys general vowing to challenge any rule changes that undermine coverage. Meanwhile, insurers are quietly modeling scenarios in which they reintroduce cost-sharing for previously free screenings. The overhaul is not yet final, but the trajectory is clear: what was once considered settled coverage for preventive care is now in play. The task force's next meeting, scheduled for August 2026, will be the first under new rules. If the overhaul proceeds, the burden will shift back to patients — either paying out-of-pocket or going without. The healthcare industry is bracing for a new era of uncertainty.
Frequently Asked Questions
The USPSTF is an independent panel of experts in prevention and evidence-based medicine. It grades preventive services (like cancer screenings) from A to D, and under the ACA, services with an A or B rating must be covered by insurance with no patient cost-sharing.
If the overhaul leads to downgraded ratings for certain screenings, insurers will no longer be required to cover them for free. You may face copays, deductibles, or full out-of-pocket costs for previously free services like mammograms or colonoscopies.
Screenings at highest risk include mammograms for women aged 40-49, colorectal cancer tests for people under 50, lung cancer CT scans for high-risk individuals, and hepatitis C tests for adults. The task force may also reassess depression screening and cholesterol checks.
A 2025 executive order required all federal advisory committees to undergo political vetting of members. The USPSTF, previously independent, now faces new leadership instructions to prioritize cost-effectiveness and align with administration priorities, prompting resignations and controversy.
Yes. Democratic attorneys general from at least 18 states have announced plans to sue if the overhaul results in reduced preventive care coverage. They argue that the ACA's preventive services mandate cannot be weakened without congressional action.
The task force's next meeting in August 2026 will operate under new membership and procedures. Final changes to rating guidelines could be published later in 2026, with insurance coverage changes likely following in 2027 after plan renewals.
